More Globe Newswire

View Older Stories View Newer Stories

Apr 8, 2026 08:00AM MicroCloud Hologram Inc. State-Based Fully Quantized Imaginary-Time Evolution Simulation Technology Reshapes the Ground State Solving Path
Apr 8, 2026 08:00AM Cowboy Clean Fuels and Absolute Climate Raise the Bar for High-Integrity Carbon Removal
Apr 8, 2026 08:00AM Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement
Apr 8, 2026 08:00AM Cerence AI to Power Intelligent, LLM-Powered In-Car Experiences for BYD
Apr 8, 2026 08:00AM HealthBook+ Launches HealthBook+ 2.0 Featuring Enhanced PaiGE, the Agentic Medical Partner, at HINT Summit 2026
Apr 8, 2026 08:00AM Belay Global SPAC Bootcamp Announces Venue Change Due to Strong Attendance Demand
Apr 8, 2026 08:00AM Westwood Announces Monthly Income Distributions for Westwood Salient Enhanced Midstream Income ETF (MDST), Westwood Salient Enhanced Energy Income ETF (WEEI) and Westwood Enhanced Income Opportunity (
Apr 8, 2026 08:00AM Game On: The Human Bean's Spring Menu Is Here to Fuel Your Best Season Yet
Apr 8, 2026 08:00AM Catheter Precision to Attend the Annual European Heart Rhythm Association Conference
Apr 8, 2026 08:00AM electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference
Apr 8, 2026 08:00AM Collegium to Participate in Upcoming Investor Conferences
Apr 8, 2026 08:00AM NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference
Apr 8, 2026 07:50AM Form 8.3 - [IDOX PLC - 07 04 2026] - (CGWL)
Apr 8, 2026 07:51AM DPM Metals Announces First Quarter 2026 Preliminary Production Results; Ramp-up of Vareš Proceeding Well
Apr 8, 2026 07:50AM Notice of Ordinary General Meeting
Apr 8, 2026 07:50AM Nasdaq Determines That 3 E Network Has Regained Compliance with Continued Listing Requirements
Apr 8, 2026 07:47AM Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline
Apr 8, 2026 07:37AM Bitget Launchpool adds Midnight (NIGHT) with 12M in Token Rewards
Apr 8, 2026 07:35AM Pecoy Copper Intersects 1,020.50 m of 0.43% Cu and 0.09 g/t Au from 48 m in Follow-Up Hole, a Second Consecutive Kilometre-Scale Intercept within South Breccia
Apr 8, 2026 07:30AM SAGA Metals Engages Dias Airborne for Advanced Geophysical Survey over Entire Oxide Layering Strike Connecting Trapper and Hawkeye Zones at Radar Critical Minerals Project in Labrador
Apr 8, 2026 07:30AM Rio Silver Inc. Reports: Initial Silver – Gold - Lead Recoveries of 85 %, 74 % and 77% Respectively From the Maria Norte in Central Peru
Apr 8, 2026 07:30AM Winshear Reports Additional Soil Sampling Results, Presenting Numerous Large Gold Targets from the 2025 Exploration Program at the Thunder Bay Project
Apr 8, 2026 07:30AM PMGC Holdings Inc. [NASDAQ: ELAB] Fully Utilizes All Available in $20M Equity Financing Facility, Strengthens Cash Position and Advances Multi-Sector Acquisition Strategy
Apr 8, 2026 07:30AM Base Carbon Provides Update on Vietnam Regulatory Framework for International Carbon Credit Transfers
Apr 8, 2026 07:30AM Tris Pharma to Showcase Encore Phase 3 Data Supporting Continued Progress in Acute Pain Treatment at ASRA 2026 Meeting in Phoenix
Apr 8, 2026 07:30AM DEEP SEA MINERALS CORP. ESTABLISHES COOK ISLANDS SUBSIDIARY TO ADVANCE CONCESSION APPLICATION PROCESS
Apr 8, 2026 07:30AM Rocket Lab Completes at the Market Offering
Apr 8, 2026 07:30AM Steele Solutions Acquires Wisconsin Manufacturer Maysteel Industries
Apr 8, 2026 07:30AM Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas
Apr 8, 2026 07:25AM Exodus Movement, Inc. March 2026 Treasury Update and Monthly Metrics
Apr 8, 2026 07:19AM Former Visa Executive Behind VAMP Joins QuickRefund as Chief Risk Intelligence Officer
Apr 8, 2026 07:05AM Fixing of coupon rates - Nykredit Realkredit A/S
Apr 8, 2026 07:00AM Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026
Apr 8, 2026 07:00AM Immusoft Announces Presentation of World's First Patient Treated with an Engineered B Cell Therapy at Workshop Co-Hosted by FDA and ARM
Apr 8, 2026 07:00AM Loblaw Companies Limited Announces the Timing of the First Quarter 2026 Earnings Release and Annual Meeting of Shareholders
Apr 8, 2026 07:01AM Software from tech startup Leto helps caseworkers connect clients with community resources
Apr 8, 2026 07:00AM BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
Apr 8, 2026 07:00AM Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Apr 8, 2026 07:00AM TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
Apr 8, 2026 07:00AM FactSet Announces Chief Financial Officer Transition
Apr 8, 2026 07:00AM Immusoft Announces Presentation of World's First Patient Treated with an Engineered B Cell Therapy at Workshop Co-Hosted by FDA and ARM
Apr 8, 2026 07:00AM Veteran Private Equity Investor Seth Harward Joins Siris as Managing Director – Business Development
Apr 8, 2026 07:00AM BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026
Apr 8, 2026 07:00AM Anfield Energy Submits Permit Amendment for JD-8 Mine Restart
Apr 8, 2026 07:00AM CEO Address to Shareholders
Apr 8, 2026 07:00AM Xali Gold Adds Permitting Expert to Development and Operations Team at Pico Machay Gold Project in Peru
Apr 8, 2026 07:00AM Tilray Expands Canadian Cannabis Portfolio with Launch of PORTAL™, A New High Intensity Brand for the Experienced Consumer
Apr 8, 2026 07:00AM Exol™ Launches U.S. Physical AI Facilities and Groundbreaking Fulfillment-as-a-Service Model to Expand Access to Enterprise-Grade Automation
Apr 8, 2026 07:00AM Capital City Bank Group, Inc. to Announce Quarterly Earnings Results on Monday, April 20, 2026
Apr 8, 2026 07:00AM Incyclix Bio Raises Additional $5 Million in Series B Financing to Advance Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors
View Newer Stories View Older Stories